Darling Ingredients Inc
Food Products
Darling Ingredients Inc (DAR) Stock News
The latest DAR headlines and market coverage — 9 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
ARGAN: STANDARD & POOR’S PLACES THE COMPANY’S “BBB-” ISSUER CREDIT RATING ON POSITIVE CREDIT WATCH
Following ARGAN's proposed merger with WDP announced on July 23, 2026, Standard & Poor's has placed ARGAN's 'BBB-' issuer credit rating on Positive CreditWatch, indicating a potential upgrade to 'BBB' upon merger completion in Q1 2027. The combined entity would benefit from increased scale, geographic diversification, reduced tenant concentration risk, and a stronger financial profile.
- GlobeNewswire Inc.·
ARGAN : STANDARD & POOR’S EMET UN CREDIT WATCH POSITIF SUR LA NOTATION « BBB- »
Following the announcement of its proposed merger with WDP, Standard & Poor's has placed ARGAN's BBB- credit rating on CreditWatch with positive outlook, signaling a potential upgrade of at least one notch. S&P cited the merger's expected benefits including increased size, strengthened rental income profile, expanded geographic diversification, and reduced client concentration risk, positioning the combined entity as a European logistics real estate leader.
- GlobeNewswire Inc.·
SPORTRADAR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sportradar Group AG Investors with Losses in Excess of $100K to Secure Counsel Before Important July 17 Deadline in Securities Class Action - SRAD
Rosen Law Firm is reminding investors in Sportradar Group AG, Hub Group, Inc., and Commvault Systems, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The Sportradar lawsuit alleges the company made false statements about compliance and worked with black-market gambling operators while misrepresenting its Know-Your-Customer processes. Similar class actions have been filed against the other companies with July 17, 2026 as a key deadline.
- GlobeNewswire Inc.·
SPORTRADAR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important July 17 Deadline in Securities Class Action - SRAD
A securities class action lawsuit has been filed against Sportradar Group AG (NASDAQ: SRAD) for allegedly making false and misleading statements regarding its compliance practices. The lawsuit claims the company intentionally worked with black-market gambling operators while publicly assuring strict legal and regulatory compliance, and that its Know-Your-Customer (KYC) processes were not as robust as claimed. Investors who purchased shares between November 7, 2024 and April 21, 2026 may be eligible for compensation. The lead plaintiff deadline is July 17, 2026.
- GlobeNewswire Inc.·
Atos Named ‘Best in Class’ in Multiple Categories Across the 2026 PAC RADAR Evaluation of SAP Service Providers
Atos has been recognized as a market leader in SAP Services by PAC in their 2026 RADAR evaluation, achieving multiple 'Best in Class' rankings across consulting, system integration, hosting, and application management. The recognition highlights Atos' strong global position, particularly in EMEA, with deep expertise in SAP BTP, cloud solutions, and AI-driven transformation capabilities.
- GlobeNewswire Inc.·
Atos nommé « Best in Class » dans plusieurs catégories dans le PAC RADAR 2026 pour les fournisseurs de services SAP
Atos has been recognized by PAC as a leader in the SAP services market for 2026, receiving 'Best in Class' ratings in multiple categories including consulting, systems integration, application management, and SAP hosting. The recognition highlights Atos's strong position in the EMEA region, its comprehensive SAP portfolio, and its strategic focus on SAP BTP, cloud sovereignty, and AI capabilities.
- GlobeNewswire Inc.·
SPORTRADAR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRAD
A securities class action lawsuit has been filed against Sportradar Group AG (NASDAQ: SRAD) for allegedly making false and misleading statements regarding compliance practices. The lawsuit claims the company intentionally worked with black-market gambling operators while misrepresenting its Know-Your-Customer processes and regulatory compliance. Investors who purchased shares between November 7, 2024 and April 21, 2026 may be eligible for compensation. The lead plaintiff deadline is July 17, 2026.
- GlobeNewswire Inc.·Neutral
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
ADARx Pharmaceuticals announced that Phase 1/2 clinical data for onvuzosiran (ADX-324), an siRNA therapeutic for hereditary angioedema (HAE), will be presented at the 2026 EAACI Annual Meeting in Istanbul. The drug is designed to reduce plasma kallikrein levels and prevent HAE attacks with reduced treatment burden. Onvuzosiran is currently in Phase 3 STOP-HAE trials and has received FDA Orphan Drug Designation.
- Seeking Alpha·Neutral
Boyd outlines $650M-$700M 2026 capex plan while reiterating $30M-$35M online EBITDAR guidance